var data={"title":"Systemic lupus erythematosus (SLE) in children: Clinical manifestations and diagnosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Systemic lupus erythematosus (SLE) in children: Clinical manifestations and diagnosis</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Marisa Klein-Gitelman, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Robert Sundel, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Elizabeth TePas, MD, MS</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Aug 16, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H75102260\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Systemic lupus erythematosus (SLE) is a chronic inflammatory disease of unknown cause that can affect the skin, joints, kidneys, lungs, nervous system, serous membranes, <span class=\"nowrap\">and/or</span> other organs of the body. SLE in children is fundamentally the same disease as in adults, with similar etiology, pathogenesis, clinical manifestations, and laboratory findings. However, the care of children and adolescents with SLE is different from that of adults because of the impact of the disease and its therapy on physical and psychologic growth and development. (See <a href=\"topic.htm?path=overview-of-the-clinical-manifestations-of-systemic-lupus-erythematosus-in-adults\" class=\"medical medical_review\">&quot;Overview of the clinical manifestations of systemic lupus erythematosus in adults&quot;</a>.)</p><p>The epidemiology, clinical features, diagnosis, and classification of SLE in children are reviewed here. The treatment, complications, and prognosis of SLE in children are discussed separately. (See <a href=\"topic.htm?path=systemic-lupus-erythematosus-sle-in-children-treatment-complications-and-prognosis\" class=\"medical medical_review\">&quot;Systemic lupus erythematosus (SLE) in children: Treatment, complications, and prognosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H75102290\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The best estimate is that SLE affects between 5000 and 10,000 children in the United States [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. Childhood SLE affects girls more often than boys (8:1), even in the prepubescent age group (4:1). SLE can occur at any age, although it becomes more frequent after five years of age and is increasingly prevalent after the first decade of life [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/2\" class=\"abstract_t\">2</a>]. In retrospective reviews from France, Canada, and the United Kingdom, the median age of onset of juvenile SLE was 12 to 13 years, with the disease developing in the majority of patients after eight years of age [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/3-5\" class=\"abstract_t\">3-5</a>]. (See <a href=\"topic.htm?path=epidemiology-and-pathogenesis-of-systemic-lupus-erythematosus#H1\" class=\"medical medical_review\">&quot;Epidemiology and pathogenesis of systemic lupus erythematosus&quot;, section on 'Epidemiology'</a>.)</p><p>Comparison of data from institutions serving racially diverse populations is generally unrevealing because the incidence and severity of childhood SLE vary by race [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/2\" class=\"abstract_t\">2</a>]. Patients of Asian, African, or Latino ethnicity are more frequently affected than Caucasians. Estimates of disease incidence among females of different ethnic groups in the United States aged 10 to 18 years are:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>31 cases per 100,000 for Asians</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>20 cases per 100,000 for blacks</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>13 cases per 100,000 for Hispanics</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>4 cases per 100,000 for whites</p><p/><p>The estimated prevalence in Asia varies from 6 cases per 100,000 in Taiwan to 19 cases per 100,000 in central Saudi Arabia [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/6-8\" class=\"abstract_t\">6-8</a>].</p><p class=\"headingAnchor\" id=\"H75102434\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The etiology of SLE remains unknown, but genetic, hormonal, immunologic, and environmental factors are suspected to play a role. Many of the clinical manifestations are mediated directly or indirectly by antibody formation and the creation of immune complexes. The etiology and pathogenesis of SLE are discussed in greater detail separately. (See <a href=\"topic.htm?path=epidemiology-and-pathogenesis-of-systemic-lupus-erythematosus\" class=\"medical medical_review\">&quot;Epidemiology and pathogenesis of systemic lupus erythematosus&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H75102452\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The presenting manifestations of SLE in children are diverse, and any organ system may be involved [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/9,10\" class=\"abstract_t\">9,10</a>]. The most common initial symptoms are the gradual onset of fever, weight loss, and malaise with general deterioration over several months, although some children have acute or even life-threatening symptoms. Children also may have small joint arthritis and renal disease, both of which are commonly overlooked before the diagnosis of SLE is established. The classic malar rash is often absent and must not be relied upon to suggest the diagnosis (<a href=\"image.htm?imageKey=DERM%2F75781\" class=\"graphic graphic_picture graphicRef75781 \">picture 1</a> and <a href=\"image.htm?imageKey=DERM%2F55875\" class=\"graphic graphic_picture graphicRef55875 \">picture 2</a>). (See <a href=\"topic.htm?path=overview-of-the-clinical-manifestations-of-systemic-lupus-erythematosus-in-adults\" class=\"medical medical_review\">&quot;Overview of the clinical manifestations of systemic lupus erythematosus in adults&quot;</a>.)</p><p>In retrospective reviews from France and Canada, the most common presenting manifestations were as follows (<a href=\"image.htm?imageKey=PEDS%2F64565\" class=\"graphic graphic_table graphicRef64565 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/3,4\" class=\"abstract_t\">3,4</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hematologic &ndash; Anemia, lymphopenia, leukopenia, <span class=\"nowrap\">and/or</span> thrombocytopenia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mucocutaneous &ndash; Malar rash <span class=\"nowrap\">and/or</span> oral ulcers</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Musculoskeletal &ndash; Arthritis or arthralgia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fever</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Renal abnormalities &ndash; Nephritis and nephrotic syndrome</p><p/><p>These manifestations, in addition to seizures and lymphadenopathy, are more common in childhood-onset lupus than adult-onset lupus, whereas Raynaud phenomenon, pleuritis, and sicca are more common manifestations in patients who are adults at disease onset [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/11\" class=\"abstract_t\">11</a>]. (See <a href=\"topic.htm?path=overview-of-the-clinical-manifestations-of-systemic-lupus-erythematosus-in-adults\" class=\"medical medical_review\">&quot;Overview of the clinical manifestations of systemic lupus erythematosus in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H75102600\"><span class=\"h2\">Hematologic abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hematologic abnormalities are common among children with SLE [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/12-18\" class=\"abstract_t\">12-18</a>]. Antiphospholipid antibodies (aPLs) and other autoantibodies are discussed below [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/19-21\" class=\"abstract_t\">19-21</a>]. (See <a href=\"#H75107337\" class=\"local\">'Laboratory findings'</a> below.)</p><p class=\"headingAnchor\" id=\"H75103037\"><span class=\"h3\">Leukopenia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Leukopenia occurs in nearly two-thirds of children at some point during the course of illness [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/13,14,22\" class=\"abstract_t\">13,14,22</a>]. Leukopenia is defined as a total white blood cell (WBC) count less than <span class=\"nowrap\">4000/microL</span> in the American College of Rheumatology (ACR) guidelines [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/23,24\" class=\"abstract_t\">23,24</a>]. Typically, the WBC count in children with SLE ranges from 2000 to <span class=\"nowrap\">4000/microL</span>. The decrease in WBC count is primarily due to a fall in absolute lymphocyte count accompanied by an increase in granulocyte percentage [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/25-27\" class=\"abstract_t\">25-27</a>]. Neutropenia is uncommon in SLE. When it occurs, it is usually associated with severe infection or drug effect (eg, <a href=\"topic.htm?path=cyclophosphamide-pediatric-drug-information\" class=\"drug drug_pediatric\">cyclophosphamide</a>). (See <a href=\"topic.htm?path=infectious-causes-of-neutropenia\" class=\"medical medical_review\">&quot;Infectious causes of neutropenia&quot;</a> and <a href=\"topic.htm?path=drug-induced-neutropenia-and-agranulocytosis\" class=\"medical medical_review\">&quot;Drug-induced neutropenia and agranulocytosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H75103133\"><span class=\"h3\">Anemia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Anemia is present in 50 to 75 percent of affected children [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/15,16,22\" class=\"abstract_t\">15,16,22</a>]. Anemia is defined as a hemoglobin concentration more than two standard deviations below the mean for age and sex (<a href=\"image.htm?imageKey=PEDS%2F101544\" class=\"graphic graphic_table graphicRef101544 \">table 2</a>). The most common types of anemia in children with SLE are anemia of chronic disease, iron deficiency anemia, and autoimmune hemolytic anemia (AIHA) [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/15,16,28\" class=\"abstract_t\">15,16,28</a>]. These may be seen separately or in combination. Other causes of anemia in SLE are rare and include severe direct antiglobulin test (Coombs') positive hemolytic anemia, autoimmune hemolysis, aplastic anemia, and pure red cell aplasia [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/29\" class=\"abstract_t\">29</a>]. An ongoing source of bleeding (eg, lungs, gastrointestinal tract) should be sought if the direct antiglobulin test is negative in the presence of an elevated reticulocyte count. (See <a href=\"#H75105129\" class=\"local\">'Pulmonary hemorrhage'</a> below.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Anemia of chronic disease</strong> &ndash; Anemia of chronic disease is the most common type of anemia in SLE. The pathophysiology is not well understood. The peripheral blood smear typically reveals a normochromic and normocytic picture but may be hypochromic and microcytic. Serum iron concentrations are usually reduced, but bone marrow examination reveals normal to increased iron stores. (See <a href=\"topic.htm?path=anemia-of-chronic-disease-inflammation\" class=\"medical medical_review\">&quot;Anemia of chronic disease/inflammation&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Iron deficiency anemia</strong> &ndash; Iron deficiency anemia is particularly common in female adolescents with SLE for three reasons:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Body mass usually increases, whereas iron stores do not.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Dietary choices tend to decrease iron intake. (See <a href=\"topic.htm?path=adolescent-eating-habits\" class=\"medical medical_review\">&quot;Adolescent eating habits&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Frequent <span class=\"nowrap\">and/or</span> heavy menstruation during the first years after menarche increases iron losses.</p><p/><p class=\"bulletIndent1\">In addition, many patients have mild gastrointestinal blood loss secondary to nonsteroidal anti-inflammatory drug (NSAID) and glucocorticoid therapy. Often, there is a combination of iron deficiency anemia and anemia of chronic disease.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Autoimmune hemolytic anemia</strong> &ndash; AIHA is a relatively common cause of anemia in children and adolescents with SLE. AIHA appears to be more common in children than the 7 to 15 percent described in adults with SLE, although studies documenting the prevalence of AIHA in children with SLE are lacking [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/30\" class=\"abstract_t\">30</a>]. (See <a href=\"topic.htm?path=hematologic-manifestations-of-systemic-lupus-erythematosus\" class=\"medical medical_review\">&quot;Hematologic manifestations of systemic lupus erythematosus&quot;</a>.)</p><p/><p class=\"bulletIndent1\">Some patients with idiopathic AIHA go on to develop SLE after months or even years. However, there is also a group of patients with idiopathic AIHA who are antinuclear antibody (ANA) positive who do not progress to full-blown SLE [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/31\" class=\"abstract_t\">31</a>]. AIHA in children with SLE is typically of mild to moderate severity, but it may be severe.</p><p/><p class=\"bulletIndent1\">AIHA in SLE is usually the warm reactive type in which immunoglobulin G (IgG) antibodies react with red cell surface antigens at 37&ordm;C (<a href=\"image.htm?imageKey=HEME%2F64888\" class=\"graphic graphic_figure graphicRef64888 \">figure 1</a>). These cells are then removed from the circulation, primarily by the spleen. (See <a href=\"topic.htm?path=autoimmune-hemolytic-anemia-in-children-classification-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Autoimmune hemolytic anemia in children: Classification, clinical features, and diagnosis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H75103374\"><span class=\"h3\">Thrombocytopenia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The reported prevalence of thrombocytopenia varies from 10 to 50 percent [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/13-17,19,32\" class=\"abstract_t\">13-17,19,32</a>]. Significant thrombocytopenia is defined as a platelet count of less than <span class=\"nowrap\">100,000/microL</span> in ACR guidelines. As a general rule, the degree of thrombocytopenia is mild, and hemorrhage is rare [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/19\" class=\"abstract_t\">19</a>]. However, the correlation between the number of platelets and the likelihood of bleeding is poor. Some patients hemorrhage with platelet counts <span class=\"nowrap\">&gt;100,000/microL,</span> whereas others have no bleeding with platelet counts <span class=\"nowrap\">&lt;50,000/microL</span>. In some cases, these differences are related to the severity and activity of other manifestations of SLE or to therapy. (See <a href=\"topic.htm?path=approach-to-the-child-with-unexplained-thrombocytopenia\" class=\"medical medical_review\">&quot;Approach to the child with unexplained thrombocytopenia&quot;</a>.)</p><p>The most common clinical manifestations of thrombocytopenia are petechiae, purpura, and ecchymoses, particularly on the lower arms and legs. Bleeding of the gums, epistaxis, unusually heavy menstrual flow, and even intracranial hemorrhage can also occur.</p><p>Thrombocytopenia in neonates may occur secondary to transplacental passage of maternal antibodies, as in neonatal lupus, a detailed discussion of which is presented separately. (See <a href=\"topic.htm?path=neonatal-lupus-epidemiology-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Neonatal lupus: Epidemiology, pathogenesis, clinical manifestations, and diagnosis&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Immune thrombocytopenia</strong> &ndash; Immune thrombocytopenia (ITP), usually a disease <em>sui generis</em>, may be the first manifestation of SLE, antedating this diagnosis by many years [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/33-36\" class=\"abstract_t\">33-36</a>]. This evolution occurs in up to 15 percent of patients with ITP [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/37\" class=\"abstract_t\">37</a>]. A greater percentage of patients with ITP who go on to develop SLE have or develop a positive ANA [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/38\" class=\"abstract_t\">38</a>]. Thus, it is important that the clinician caring for a child with a positive ANA and ITP periodically look for evidence of SLE manifestations in other organ systems. (See <a href=\"topic.htm?path=immune-thrombocytopenia-itp-in-children-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Immune thrombocytopenia (ITP) in children: Clinical features and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Thrombotic thrombocytopenic purpura</strong> &ndash; Thrombotic thrombocytopenic purpura (TTP) is rare in children, and it is an uncommon acute and life-threatening complication in children with SLE [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/39-41\" class=\"abstract_t\">39-41</a>]. It may be the initial presenting feature. The pentad of fever, thrombocytopenia, neurologic and renal abnormalities, and a microangiopathic hemolytic anemia is caused by the presence of an antibody to a von Willebrand factor-cleaving protease [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/42\" class=\"abstract_t\">42</a>]. (See <a href=\"topic.htm?path=pathophysiology-of-acquired-ttp-and-other-primary-thrombotic-microangiopathies-tmas\" class=\"medical medical_review\">&quot;Pathophysiology of acquired TTP and other primary thrombotic microangiopathies (TMAs)&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H75103685\"><span class=\"h2\">Mucocutaneous manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Skin and mucous membrane findings include the butterfly (malar) rash (<a href=\"image.htm?imageKey=DERM%2F75781\" class=\"graphic graphic_picture graphicRef75781 \">picture 1</a> and <a href=\"image.htm?imageKey=DERM%2F55875\" class=\"graphic graphic_picture graphicRef55875 \">picture 2</a>) and oral <span class=\"nowrap\">and/or</span> nasal ulcers. However, the classic skin findings are often absent in children on presentation. Less common findings of skin involvement in children include maculopapular rash, discoid lesions, nonscarring alopecia, cutaneous vasculitis, and Raynaud phenomenon [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/43\" class=\"abstract_t\">43</a>]. Mucocutaneous involvement in SLE is reviewed in greater detail separately. (See <a href=\"topic.htm?path=overview-of-cutaneous-lupus-erythematosus\" class=\"medical medical_review\">&quot;Overview of cutaneous lupus erythematosus&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H75103752\"><span class=\"h2\">Musculoskeletal involvement</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common musculoskeletal findings in children with SLE are arthritis and arthralgias. Bone abnormalities include osteopenia and osteonecrosis [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/44\" class=\"abstract_t\">44</a>]. These manifestations are discussed in greater detail separately. Vitamin D deficiency is discussed below. (See <a href=\"topic.htm?path=musculoskeletal-manifestations-of-systemic-lupus-erythematosus\" class=\"medical medical_review\">&quot;Musculoskeletal manifestations of systemic lupus erythematosus&quot;</a> and <a href=\"#H75107640\" class=\"local\">'Vitamin D deficiency'</a> below.)</p><p>In one case series of 64 consecutive children with SLE, dual x-ray absorptiometry (DXA) scanning demonstrated lumbar spine osteopenia in 24 patients (38 percent), osteoporosis in 13 (20 percent), and decreased hip bone mineral density (BMD) in 12 patients (19 percent) [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/44\" class=\"abstract_t\">44</a>]. These findings are primarily due to glucocorticoid toxicity. (See <a href=\"topic.htm?path=musculoskeletal-manifestations-of-systemic-lupus-erythematosus#H10\" class=\"medical medical_review\">&quot;Musculoskeletal manifestations of systemic lupus erythematosus&quot;, section on 'Osteoporosis'</a>.)</p><p class=\"headingAnchor\" id=\"H75103821\"><span class=\"h2\">Fever</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Low-grade fever and malaise are common manifestations of early SLE and other systemic illnesses. Fevers above 38.6&deg;C (101.5&deg;F) may occur, but infection should always be excluded in these cases.</p><p class=\"headingAnchor\" id=\"H75103827\"><span class=\"h2\">Neurologic involvement</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>SLE is often associated with a variety of neuropsychiatric manifestations [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/45-52\" class=\"abstract_t\">45-52</a>]. Headache is a frequent complaint. Adolescents commonly present with progressive deterioration in academic performance, withdrawal, depression, and social isolation. Often these findings initially are thought to represent teenage adjustment problems. SLE is only suspected when a full physical assessment and appropriate laboratory tests are performed [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/53\" class=\"abstract_t\">53</a>]. More dramatic neurologic presentations of SLE include seizures, chorea, stroke, dementia, and coma. These may be accompanied by cranial neuropathies <span class=\"nowrap\">and/or</span> evidence of cerebritis. Neurologic manifestations of SLE are discussed in greater detail separately. (See <a href=\"topic.htm?path=neurologic-manifestations-of-systemic-lupus-erythematosus\" class=\"medical medical_review\">&quot;Neurologic manifestations of systemic lupus erythematosus&quot;</a> and <a href=\"topic.htm?path=neuropsychiatric-manifestations-of-systemic-lupus-erythematosus\" class=\"medical medical_review\">&quot;Neuropsychiatric manifestations of systemic lupus erythematosus&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H75104051\"><span class=\"h2\">Renal disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Renal involvement in SLE may vary from the detection of hematuria and proteinuria on routine examination to the presence of nephrotic syndrome or acute renal failure. Some degree of renal involvement is present in two-thirds of children with SLE evaluated at major medical centers [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/54\" class=\"abstract_t\">54</a>]. A higher rate of lupus nephritis was seen in adolescent-onset SLE compared with adult-onset in one series [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/55\" class=\"abstract_t\">55</a>]. (See <a href=\"topic.htm?path=acute-kidney-injury-in-children-clinical-features-etiology-evaluation-and-diagnosis\" class=\"medical medical_review\">&quot;Acute kidney injury in children: Clinical features, etiology, evaluation, and diagnosis&quot;</a> and <a href=\"topic.htm?path=diagnosis-and-classification-of-renal-disease-in-systemic-lupus-erythematosus\" class=\"medical medical_review\">&quot;Diagnosis and classification of renal disease in systemic lupus erythematosus&quot;</a>.)</p><p>Lupus nephritis was identified in 37 percent of children with SLE enrolled in Medicaid from 2000 to 2004 in the United States [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/56\" class=\"abstract_t\">56</a>]. Diffuse proliferative (class IV) lupus nephritis occurs in approximately 20 percent of all children presenting for evaluation in whom a renal biopsy is performed, independent of the presence or absence of active disease [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/57\" class=\"abstract_t\">57</a>]. This likely represents an overestimate of the actual incidence of renal disease since the incidence is probably lower in children without clinical evidence of renal disease who are not biopsied. However, mild lupus nephritis is relatively common in some populations. In addition, patients who received glucocorticoid therapy prior to evaluation and diagnosis of SLE may have unreliable urine studies and should be biopsied to evaluate for lupus nephritis. (See <a href=\"topic.htm?path=diagnosis-and-classification-of-renal-disease-in-systemic-lupus-erythematosus\" class=\"medical medical_review\">&quot;Diagnosis and classification of renal disease in systemic lupus erythematosus&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H75104147\"><span class=\"h2\">Pulmonary disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pulmonary disease is a common and well-documented component of SLE in children and may signal onset of the disease. Children rarely present with predominant complaints of shortness of breath, but they may have chest pain [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/13-15,18,58-64\" class=\"abstract_t\">13-15,18,58-64</a>]. Most reviews of childhood lupus report respiratory findings in 30 to 50 percent of cases, with pleuritis being the most common finding. Subclinical lung disease (eg, restrictive lung disease or reduced diffusion capacity identified through pulmonary function testing [PFT] with diffusing capacity for carbon monoxide [DLCO]) is present in as many as 60 to 70 percent of patients who are tested [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/58,65,66\" class=\"abstract_t\">58,65,66</a>]. As such, PFTs with DLCO should be performed periodically in asymptomatic patients and whenever there are new or increasing complaints of shortness of breath. Some centers perform PFTs annually in children with SLE, but there is no agreed standard in the absence of symptoms. Acute pulmonary hemorrhage and pulmonary hypertension are the most severe forms of lupus-associated pulmonary involvement, although they occur infrequently in children with SLE. Pulmonary hemorrhage is an acute emergency when it presents. Other pulmonary manifestations of SLE in children include pneumonia, shrinking lung syndrome, pneumonitis, and pneumothorax [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/9,65\" class=\"abstract_t\">9,65</a>].</p><p class=\"headingAnchor\" id=\"H75104535\"><span class=\"h3\">Pleuritis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pleuritis is inflammation of the parietal and visceral pleura of the lung and is a form of serositis, one of the disease classification criteria (<a href=\"image.htm?imageKey=RHEUM%2F86633\" class=\"graphic graphic_table graphicRef86633 \">table 3</a>) [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/23\" class=\"abstract_t\">23</a>]. It occurs in approximately 30 to 35 percent of children with SLE [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/15,23,58\" class=\"abstract_t\">15,23,58</a>]. Pleuritis may present at any time during the course of the disease. (See <a href=\"#H75107738\" class=\"local\">'Diagnosis'</a> below.)</p><p>The suspected etiology of pleuritis in patients with SLE is an autoimmune process, although the precise pathophysiology is not known. Pleuritis and pleural effusion may also be caused by infections, nephrosis, and recurrent pulmonary emboli. Cardiac disease may be associated with pleural effusions.</p><p>Pleuritic chest pain is caused by irritation of the nerve endings of pain fibers in the parietal pleura [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/67\" class=\"abstract_t\">67</a>]. Children with pleuritis typically complain of chest pain that is sharp (&quot;stabbing&quot;), often severe, varies with respiration, and is usually well localized. Pain referred from the pleura may be felt anteriorly or posteriorly in areas of skin innervated by the intercostal nerves [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/67\" class=\"abstract_t\">67</a>]. The pain may be intermittent and is exacerbated by deep inspiration. The child may be more comfortable sitting or standing than in the supine or prone positions. Chest pain may be accompanied by cough, low-grade fever, and malaise. Pneumonia and pericarditis may have similarly presenting manifestations.</p><p>On physical examination, tachypnea and tachycardia are present with or without fever. The child often appears anxious. Auscultation may reveal a pleural rub or decreased breath sounds. There may also be decreased air exchange caused by splinting from pain.</p><p>The diagnosis of pleuritis in a child with SLE is usually made with plain radiographs of the chest that demonstrate pleural fluid on one or both sides [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/68\" class=\"abstract_t\">68</a>]. Large pleural effusions are uncommon. Pleural thickening may be present.</p><p>High-resolution computed tomography (CT) is sometimes obtained to exclude other causes of chest pain when the routine chest radiographs do not provide an answer. PFTs, determination of arterial blood gases, and other diagnostic studies usually are not necessary in typical cases of pleuritis. Recurrent pleuritis warrants further investigation, as do other chronic pulmonary symptoms or signs. Thoracentesis is unnecessary unless infection is suspected.</p><p class=\"headingAnchor\" id=\"H75104669\"><span class=\"h3\">Subclinical abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Subclinical abnormalities, identified by PFTs, are common in children with SLE [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/23,58,62,69-72\" class=\"abstract_t\">23,58,62,69-72</a>]. In one study of 22 children with SLE, 13 patients who were without respiratory signs or symptoms and who had normal chest radiographs had abnormal PFTs [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/58\" class=\"abstract_t\">58</a>]. The abnormalities identified in this and other studies are primarily restrictive in nature, with reduced diffusion capacity [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/62\" class=\"abstract_t\">62</a>]. (See <a href=\"topic.htm?path=overview-of-pulmonary-function-testing-in-children\" class=\"medical medical_review\">&quot;Overview of pulmonary function testing in children&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Shrinking lung syndrome</strong> &ndash; The cause of abnormal PFTs in patients without signs or symptoms is not always clear. One unusual cause of progressive restrictive pulmonary dysfunction unique to patients with SLE is the shrinking or vanishing lung syndrome [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/73\" class=\"abstract_t\">73</a>]. Shrinking lung syndrome is an entity in which the vital capacity decreases over time in the absence of extensive parenchymal fibrosis or pleural disease. It usually is the result of malfunctioning respiratory muscles, especially the diaphragm [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/74,75\" class=\"abstract_t\">74,75</a>]. It has been reported in adults [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/76-78\" class=\"abstract_t\">76-78</a>] and children [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/58,62,79,80\" class=\"abstract_t\">58,62,79,80</a>], and it may progress to cause severe respiratory dysfunction. This syndrome has been treated successfully with glucocorticoids [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/81\" class=\"abstract_t\">81</a>].</p><p/><p class=\"headingAnchor\" id=\"H75105129\"><span class=\"h3\">Pulmonary hemorrhage</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute and chronic pulmonary hemorrhages are rare but serious complications of SLE in children. (See <a href=\"topic.htm?path=hemoptysis-in-children\" class=\"medical medical_review\">&quot;Hemoptysis in children&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Acute pulmonary hemorrhage</strong> &ndash; Acute pulmonary hemorrhage is one of the most severe forms of pulmonary involvement in patients with SLE. It occurs in less than 5 percent of children with SLE [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/18,63,64,82-86\" class=\"abstract_t\">18,63,64,82-86</a>]. Acute severe bleeding is seen most often in children with active multisystem disease.</p><p/><p class=\"bulletIndent1\">The clinical manifestations of acute pulmonary hemorrhage include fever, cough, fatigue, pallor, tachypnea, and epistaxis or hemoptysis. Any child with SLE who experiences acute shortness of breath with a sudden drop in hemoglobin should be evaluated promptly for pulmonary hemorrhage. The size of the hemorrhage is variable, and visible bleeding is not always present. Some children with chronic low-grade bleeding can be detected by finding hemosiderin-laden macrophages in the sputum. However, many children with significant hemorrhage are not able to give an adequate sputum specimen, and absence of this finding does not rule out pulmonary hemorrhage. Hemoptysis in children with SLE may also be an indication of infection, pulmonary embolism, or heart failure, as well as less common conditions. (See <a href=\"topic.htm?path=hemoptysis-in-children\" class=\"medical medical_review\">&quot;Hemoptysis in children&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Chronic pulmonary hemorrhage</strong> &ndash; Chronic pulmonary hemorrhage is an often unsuspected source of bleeding in children with active SLE. Children with chronic pulmonary hemorrhage may present simply with chronic anemia. The diagnosis is often made in the setting of a persistent cough with infiltrates noted on chest radiograph. Persistent elevation of the reticulocyte count in combination with a negative direct antiglobulin (Coombs') test is also suggestive of chronic pulmonary hemorrhage, although a positive Coombs' test does not exclude the diagnosis. Some children have chronic pulmonary hemorrhage for months or years, but the sudden onset of acute severe bleeding (ie, acute pulmonary hemorrhage) may occur in this setting.</p><p/><p class=\"headingAnchor\" id=\"H75105365\"><span class=\"h3\">Pulmonary hypertension</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Similar to pulmonary hemorrhage, pulmonary hypertension is a rare but severe pulmonary complication of childhood SLE. It is described in case series (occurring in less than 1 percent of cases) and case reports [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/13-15,17,18,58,62,64,87\" class=\"abstract_t\">13-15,17,18,58,62,64,87</a>]. In children with SLE, pulmonary hypertension is thought to be caused by multiple, small pulmonary emboli [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/88\" class=\"abstract_t\">88</a>].</p><p>Symptoms of pulmonary hypertension include dyspnea on exertion, fatigue, lethargy, chest pain, exertional syncope, cough, hemoptysis, and hoarseness (caused by compression of the left recurrent laryngeal nerve by a dilated main pulmonary artery). Characteristic physical examination findings include increased intensity of the pulmonic component of the second heart sound, systolic ejection murmur, and, in more severe disease, a diastolic pulmonic regurgitation murmur. The diagnosis of pulmonary hypertension is confirmed by demonstrating increased pulmonary arterial systolic pressure. It should be suspected in any child with increasing tricuspid insufficiency on echocardiogram.</p><p class=\"headingAnchor\" id=\"H75105607\"><span class=\"h3\">Pneumonitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute pneumonitis is occasionally seen in patients with SLE. Chronic pneumonitis is more common in older patients but is usually subclinical.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Acute pneumonitis</strong> &ndash; Acute pneumonitis is an uncommon manifestation of SLE, occurring in 10 to 15 percent of patients with pulmonary abnormalities [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/58,63,64,71\" class=\"abstract_t\">58,63,64,71</a>]. It can occur at any time point in childhood SLE. Acute pneumonitis typically presents with fever, cough, respiratory distress, hypoxia, and, rarely, hemoptysis. Chest pain also may be present. On physical examination, patients are tachypneic and may have basal crepitations or central cyanosis.</p><p/><p class=\"bulletIndent1\">Acute pneumonitis is often confused with pneumonia. Plain radiographs may demonstrate diffuse acinar infiltrates, particularly in the lower lung fields, and pleural effusion. Children with pneumonitis may have a lower fever and more widespread abnormalities upon auscultation compared with those with pneumonia because there is more diffuse lung involvement. Both conditions are associated with a leukocytosis, but patients with pneumonia are likely to have a greater increase in the number of neutrophils. High-resolution CT will differentiate these conditions.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Chronic pneumonitis</strong> &ndash; Chronic interstitial disease is often clinically unrecognized, but it presents at autopsy in most patients with SLE. It is seen with increasing frequency in patients with childhood-onset SLE who live into their 20s and 30s. (See <a href=\"topic.htm?path=pulmonary-manifestations-of-systemic-lupus-erythematosus-in-adults#H12\" class=\"medical medical_review\">&quot;Pulmonary manifestations of systemic lupus erythematosus in adults&quot;, section on 'Interstitial lung disease'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H75105701\"><span class=\"h2\">Cardiac abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pericarditis is the most common cardiac abnormality in children with SLE, but other problems, such as myocarditis, valvular disease (eg, endocarditis), and coronary artery disease (CAD), can occur. Cardiac abnormalities in children with SLE are often silent.</p><p>The prevalence of clinical heart disease among children with SLE ranges in various studies from 12 to 54 percent [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/13,15-18,89-91\" class=\"abstract_t\">13,15-18,89-91</a>]. Subclinical disease, detected by echocardiography or found in autopsy studies, also occurs in many children [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/65,92,93\" class=\"abstract_t\">65,92,93</a>]. In a retrospective review of 40 children with SLE who had at least one echocardiogram, 68 percent of subjects (27 of 40) had abnormalities [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/65\" class=\"abstract_t\">65</a>]. These abnormalities were persistent in 5 of 14 subjects who had a second echocardiogram, of whom three were found to have moderately severe cardiac defects.</p><p class=\"headingAnchor\" id=\"H75105945\"><span class=\"h3\">Pericardial disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pericarditis is common in children with SLE, particularly within the first six months of diagnosis, and is clinically significant in nearly one-quarter [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/15,91\" class=\"abstract_t\">15,91</a>]. The classic presentation is an acute, sharp, anterior chest pain, often accompanied by dyspnea. Inspiration exacerbates the pain, which may be alleviated by an upright forward leaning position. On physical examination, low-grade fever, tachycardia, and tachypnea are commonly present. A pericardial rub also may be heard. (See <a href=\"topic.htm?path=auscultation-of-heart-sounds\" class=\"medical medical_review\">&quot;Auscultation of heart sounds&quot;</a>.)</p><p>The diagnosis of pericarditis is suspected from the history and physical examination. ST-T wave changes on electrocardiogram (ECG) may also suggest the diagnosis. Echocardiography is an effective, noninvasive method of documenting the presence of fluid around the heart. However, it may not be diagnostic in certain cases, such as those marked by small posterior pericardial effusions, or by pericardial inflammation with minimal fluid. The differential diagnosis of pericarditis includes pulmonary embolism and myocardial infarction. (See <a href=\"topic.htm?path=clinical-presentation-evaluation-and-diagnosis-of-the-nonpregnant-adult-with-suspected-acute-pulmonary-embolism\" class=\"medical medical_review\">&quot;Clinical presentation, evaluation, and diagnosis of the nonpregnant adult with suspected acute pulmonary embolism&quot;</a> and <a href=\"topic.htm?path=criteria-for-the-diagnosis-of-acute-myocardial-infarction\" class=\"medical medical_review\">&quot;Criteria for the diagnosis of acute myocardial infarction&quot;</a> and <a href=\"#H75106688\" class=\"local\">'Coronary artery disease'</a> below.)</p><p>Pericardial fluid, which may be withdrawn to relieve pressure or exclude infection, may contain ANAs and immune complexes typical of lupus [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/94\" class=\"abstract_t\">94</a>]. The glucose concentration should be normal, but the protein concentration can vary. Pericardial histopathology demonstrates foci of inflammation that are usually composed predominantly of mononuclear cells. Scarring may be prominent in recurrent disease.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Cardiac tamponade</strong> &ndash; Large pericardial effusions may accumulate without symptoms until they cause cardiac tamponade. These children present with symptoms suggestive of heart failure and accompanied by findings of distant heart sounds, pulsus paradoxus, hepatomegaly, and jugular venous distention. The diagnosis is suggested by enlargement of the cardiac silhouette on chest radiographs (ie, water bottle-shaped heart) and confirmed by echocardiography. Although cardiac tamponade is rare in children, it may be the initial manifestation of the disease [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/95-99\" class=\"abstract_t\">95-99</a>]. Constrictive pericarditis typically follows repeated episodes of chest pain in childhood SLE [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/100\" class=\"abstract_t\">100</a>]. Severe cases may require surgical intervention. (See <a href=\"topic.htm?path=constrictive-pericarditis\" class=\"medical medical_review\">&quot;Constrictive pericarditis&quot;</a> and <a href=\"topic.htm?path=recurrent-pericarditis\" class=\"medical medical_review\">&quot;Recurrent pericarditis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H75106209\"><span class=\"h3\">Myocardial disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Subclinical myocardial disease is documented at autopsy more commonly than would be expected [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/16,101-103\" class=\"abstract_t\">16,101-103</a>], but clinically significant myocarditis is rare in children with SLE [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/91,104\" class=\"abstract_t\">91,104</a>].</p><p>The clinical presentations of myocarditis are varied in nature and severity (<a href=\"image.htm?imageKey=CARD%2F66776\" class=\"graphic graphic_table graphicRef66776 \">table 4</a>). At onset, myocarditis may manifest as tachycardia. Worsening myocarditis may be evidenced by gallop rhythm, murmur, arrhythmia, pulmonic congestion, or hepatomegaly. ECG findings are nonspecific and may include decreased voltages and inverted T waves. Myocarditis is best diagnosed and evaluated by echocardiography, which typically shows evidence of decreased myocardial contractility. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-myocarditis-in-children\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of myocarditis in children&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H75106332\"><span class=\"h3\">Valvular heart disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Echocardiographic evaluation of children with SLE suggests that valvular lesions in childhood SLE are uncommon [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/65,92,103,105\" class=\"abstract_t\">65,92,103,105</a>]. The classic cardiac lesion of Libman-Sacks endocarditis (described below) was present in one-half (7 of 14) of patients in an autopsy study from 1960 [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/16\" class=\"abstract_t\">16</a>]. However, the lesions were less frequently found in subsequent studies [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/15,17\" class=\"abstract_t\">15,17</a>].</p><p>Granular, vegetative lesions are typically present on the surfaces or edges of the valves in patients with Libman-Sacks endocarditis. They also may be found on the chordae tendineae, papillary muscles, and the atrial or ventricular walls (<a href=\"image.htm?imageKey=RHEUM%2F79709\" class=\"graphic graphic_picture graphicRef79709 \">picture 3</a>). The lesions are composed of mononuclear cells, fibrin, and platelet thrombi. A major complication is infection and subsequent subacute bacterial endocarditis. Children with Libman-Sacks endocarditis may or may not have a clinically significant or changing murmur [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/106\" class=\"abstract_t\">106</a>]. Blood cultures and echocardiography should be performed whenever a new or changing murmur is noted in a patient with SLE because infective endocarditis can develop in asymptomatic patients [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/107-110\" class=\"abstract_t\">107-110</a>].</p><p>The relevance of antiphospholipid antibodies to the development of cardiac valve disease is controversial, although a strong association between autoantibodies and both valvulitis and Libman-Sacks endocarditis has been reported [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/111-113\" class=\"abstract_t\">111-113</a>]. Sj&ouml;gren syndrome antibodies A and B <span class=\"nowrap\">(SSA/Ro</span> and <span class=\"nowrap\">SSB/La)</span> are also associated with higher frequency of valvular disease in children with SLE [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/91\" class=\"abstract_t\">91</a>]. These may represent concordant findings in more severe disease rather than a pathogenic association [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/106-110\" class=\"abstract_t\">106-110</a>]. (See <a href=\"#H75107337\" class=\"local\">'Laboratory findings'</a> below.)</p><p class=\"headingAnchor\" id=\"H75106688\"><span class=\"h3\">Coronary artery disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Children with SLE have an increased risk for early atherosclerosis and CAD that may not become clinically apparent until they are young adults [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/114\" class=\"abstract_t\">114</a>]. CAD directly impacts the long-term prognosis of children with SLE, particularly since the first recognized manifestation of CAD in children with SLE is often myocardial infarction [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/103,115-117\" class=\"abstract_t\">103,115-117</a>]. Improved control of the acute inflammatory manifestations of SLE has dramatically improved life expectancy. (See <a href=\"topic.htm?path=diseases-associated-with-atherosclerosis-in-childhood#H8\" class=\"medical medical_review\">&quot;Diseases associated with atherosclerosis in childhood&quot;, section on 'Chronic inflammatory diseases'</a>.)</p><p>In one study, 5 of 40 children with SLE (30 females, mean age 15.9 years) without symptoms or history of ischemic heart disease had abnormal coronary perfusion when evaluated [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/92\" class=\"abstract_t\">92</a>]. Total plaque burden correlates with lupus disease duration, low vitamin D levels, and failure to use angiotensin-converting enzyme (ACE) inhibitors in African-American patients [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/118\" class=\"abstract_t\">118</a>]. Prolonged use of moderate- to high-dose glucocorticoids is considered the predominant risk factor for CAD in children with SLE by many [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/119,120\" class=\"abstract_t\">119,120</a>]. However, there are contrary reports regarding the relative role of the disease itself versus glucocorticoids [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/121\" class=\"abstract_t\">121</a>]. Nonetheless, the use of glucocorticoids is a known risk factor for myocardial infarction [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/122\" class=\"abstract_t\">122</a>]. (See <a href=\"topic.htm?path=systemic-lupus-erythematosus-sle-in-children-treatment-complications-and-prognosis#H75096333\" class=\"medical medical_review\">&quot;Systemic lupus erythematosus (SLE) in children: Treatment, complications, and prognosis&quot;, section on 'Prognosis'</a>.)</p><p>There are a variety of possible explanations for the increased prevalence of CAD in children with SLE, which are not exclusive, and most likely each plays a role in its pathogenesis [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/13,17,115,116,123\" class=\"abstract_t\">13,17,115,116,123</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Elevation of serum lipids is common at presentation [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/124\" class=\"abstract_t\">124</a>] and persists because of active disease or glucocorticoid therapy [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/125-128\" class=\"abstract_t\">125-128</a>]. Dyslipidemia contributes to accelerated arteriosclerosis. (See <a href=\"topic.htm?path=risk-factors-and-development-of-atherosclerosis-in-childhood#H7\" class=\"medical medical_review\">&quot;Risk factors and development of atherosclerosis in childhood&quot;, section on 'Dyslipidemia'</a> and <a href=\"topic.htm?path=dyslipidemia-in-children-definition-screening-and-diagnosis#H235228225\" class=\"medical medical_review\">&quot;Dyslipidemia in children: Definition, screening, and diagnosis&quot;, section on 'Introduction'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Inflammation may affect the coronary arteries directly.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Systemic hypertension, another common feature of SLE, may affect the coronary arteries indirectly.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lymphopenia, which occurs in approximately two-thirds of patients with SLE, is associated with progressive carotid intima-media wall thickness [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/129\" class=\"abstract_t\">129</a>]. The absence of a clear mechanism for this association suggests that lymphopenia may be a surrogate marker for disease activity. However, an association between lymphopenia and Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) scores was not seen. Thus, the basis of this association remains unresolved.</p><p/><p>Children with SLE presenting with severe chest pain must be evaluated for the possibility of myocardial infarction. However, the majority of children with CAD are asymptomatic. Echocardiography and necropsy studies reveal CAD in a significant number of adolescents with SLE without prior physical or historical evidence of CAD. Most chest pain in children with SLE is caused by pleuritis or pericarditis, but other causes, such as CAD or pulmonary emboli, must be considered in the differential diagnosis because of their potentially grave consequences. (See <a href=\"#H75104535\" class=\"local\">'Pleuritis'</a> above and <a href=\"#H75105945\" class=\"local\">'Pericardial disease'</a> above and <a href=\"topic.htm?path=overview-of-acute-pulmonary-embolism-in-adults\" class=\"medical medical_review\">&quot;Overview of acute pulmonary embolism in adults&quot;</a> and <a href=\"topic.htm?path=clinical-presentation-evaluation-and-diagnosis-of-the-nonpregnant-adult-with-suspected-acute-pulmonary-embolism\" class=\"medical medical_review\">&quot;Clinical presentation, evaluation, and diagnosis of the nonpregnant adult with suspected acute pulmonary embolism&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H75107270\"><span class=\"h3\">Heart failure</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Heart failure in children with SLE is usually the result of renal or pulmonary compromise (eg, hypertension, glomerulonephritis <span class=\"nowrap\">and/or</span> nephrosis, and pulmonary disease) rather than intrinsic cardiac disease. (See <a href=\"#H75104051\" class=\"local\">'Renal disease'</a> above and <a href=\"#H75104147\" class=\"local\">'Pulmonary disease'</a> above.)</p><p class=\"headingAnchor\" id=\"H75107305\"><span class=\"h2\">Gastrointestinal disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gastrointestinal involvement occurs in approximately 20 percent of children with SLE. In one case series, 39 of 201 children with SLE had gastrointestinal involvement [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/130\" class=\"abstract_t\">130</a>]. Symptoms included pain due to ascites (n = 14), pancreatitis (n = 12), or complications of treatment (n = 1) or infection (n = 1). Pancreatitis in particular has increased morbidity. Mild hepatitis is a frequent finding at disease onset. It is usually asymptomatic, although it is accompanied by hepatosplenomegaly. Hepatitis resolves with initial treatment. (See <a href=\"topic.htm?path=gastrointestinal-manifestations-of-systemic-lupus-erythematosus\" class=\"medical medical_review\">&quot;Gastrointestinal manifestations of systemic lupus erythematosus&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H75107337\"><span class=\"h1\">LABORATORY FINDINGS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Common laboratory findings in children with SLE, in addition to the hematologic abnormalities discussed above, include presence of autoantibodies such as antinuclear antibodies (ANAs), antiphospholipid antibodies (aPLs), and vitamin D deficiency. These findings are in addition to the common markers of inflammation that are elevated, such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Findings more specific to SLE include hypocomplementemia and urinary sediment abnormalities. (See <a href=\"#H75102600\" class=\"local\">'Hematologic abnormalities'</a> above and <a href=\"topic.htm?path=diagnosis-and-differential-diagnosis-of-systemic-lupus-erythematosus-in-adults#H4\" class=\"medical medical_review\">&quot;Diagnosis and differential diagnosis of systemic lupus erythematosus in adults&quot;, section on 'Laboratory testing'</a> and <a href=\"topic.htm?path=overview-of-the-clinical-manifestations-of-systemic-lupus-erythematosus-in-adults#H13\" class=\"medical medical_review\">&quot;Overview of the clinical manifestations of systemic lupus erythematosus in adults&quot;, section on 'Renal involvement'</a> and <a href=\"topic.htm?path=overview-of-the-clinical-manifestations-of-systemic-lupus-erythematosus-in-adults#H19\" class=\"medical medical_review\">&quot;Overview of the clinical manifestations of systemic lupus erythematosus in adults&quot;, section on 'Hematologic abnormalities'</a>.)</p><p>The presence of any hematologic findings should prompt testing for ANA once leukemia and other hematologic malignancies have been excluded. If an elevated ANA titer is found, the patients should be carefully evaluated for other manifestations of SLE [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/19-21\" class=\"abstract_t\">19-21</a>].</p><p class=\"headingAnchor\" id=\"H75107488\"><span class=\"h2\">Autoantibodies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In most series, 100 percent of children with SLE are ANA positive. Occasional cases of &quot;ANA-negative&quot; SLE are described, although the concept is controversial, and an ANA-negative child should be vigorously evaluated for alternative diagnoses. Additional autoantibodies such as anti-double-stranded deoxyribonucleic acid (anti-dsDNA) and anti-Smith (anti-Sm) help to confirm the diagnosis of SLE but are not uniformly present. Antibodies to Ro, La, and ribonucleoprotein (RNP) are found with varying frequency and are less strongly associated with SLE. All of these antibodies may be found in children who do not fulfill the American College of Rheumatology (ACR) criteria for classification of SLE. Some of these children will go on to develop SLE, while others will develop other rheumatic diseases, and some will remain asymptomatic. The diagnostic utility of these tests varies with the population under study.</p><p>The prevalence of aPL in children and adolescents with SLE has been evaluated in several small, cross-sectional, cohort studies and ranges from 24 to 62 percent for lupus anticoagulant (LA) to 27 to 66 percent for anticardiolipin antibodies [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/20,131\" class=\"abstract_t\">20,131</a>]. aPLs are associated with thrombocytopenia, prolonged clotting times (eg, activated partial thromboplastin time), menorrhagia, unexplained thrombosis, and stroke [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/12,19\" class=\"abstract_t\">12,19</a>]. However, aPLs are also found in many children with SLE without these complications. At times, a high titer aPL may be the only manifestation of SLE in a child with a positive ANA. Children and adolescents with SLE who have aPL should be presumed to have the same increased risk of developing a clotting disorder as adults with aPL [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/19-21\" class=\"abstract_t\">19-21</a>], and they should be treated accordingly. (See <a href=\"topic.htm?path=clinical-manifestations-of-antiphospholipid-syndrome\" class=\"medical medical_review\">&quot;Clinical manifestations of antiphospholipid syndrome&quot;</a>.)</p><p>Antineutrophil cytoplasmic antibodies (ANCAs) are observed in SLE. However, their presence is not associated with disease activity or specific organ involvement [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/45\" class=\"abstract_t\">45</a>].</p><p>Antiribosomal P antibodies are associated with active disease, particularly neuropsychiatric, renal, or hepatic involvement, and are found more frequently in children than adults [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/132,133\" class=\"abstract_t\">132,133</a>].</p><p class=\"headingAnchor\" id=\"H75107640\"><span class=\"h2\">Vitamin D deficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vitamin D deficiency has been reported in children and adolescents with SLE and may contribute to decreased bone density and osteopenia [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/134\" class=\"abstract_t\">134</a>]. Treatment consists of vitamin D supplementation. (See <a href=\"topic.htm?path=vitamin-d-insufficiency-and-deficiency-in-children-and-adolescents#H23365861\" class=\"medical medical_review\">&quot;Vitamin D insufficiency and deficiency in children and adolescents&quot;, section on 'Treatment'</a>.)</p><p>Hypovitaminosis D, which is also seen in adults with SLE, is thought to be due to avoidance of sun exposure, which is recommended to reduce the risk of inflammation and disease flares. Renal disease may also play a role in low vitamin D levels. Two studies have found an inverse correlation between serum concentrations of vitamin D and standardized disease activity scores, suggesting that hypovitaminosis D may have contributed to the development of active disease [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/135,136\" class=\"abstract_t\">135,136</a>]. However, an earlier study did not identify such a correlation [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/137\" class=\"abstract_t\">137</a>].</p><p>There are no available data on the effects of vitamin D supplementation on skeletal manifestations or disease activity in children with SLE. Until further data are available, children with SLE can be supplemented with an age-appropriate daily multivitamin to minimize the risk of hypovitaminosis D and other vitamin deficiencies. However, higher doses are not warranted based upon available data unless deficiency of vitamin D has been documented.</p><p class=\"headingAnchor\" id=\"H75107738\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of SLE is generally based upon clinical judgment after excluding alternative diagnoses. In the absence of SLE diagnostic criteria, SLE classification criteria are often used by clinicians as guidance to help identify some of the salient clinical features when making the diagnosis. Serologic findings are important to suggesting the possibility of SLE. Children who fulfill the American College of Rheumatology (ACR) criteria referenced below are considered to have definite SLE. However, not all of the manifestations required for a definite diagnosis may be present when the child is first seen. There are no official criteria for probable or possible SLE. Children with two or three classification criteria may go on to develop a fourth over time, but others may ultimately develop SLE without fulfilling the classification criteria. The key to proper care is to appropriately treat the manifestations present when the child is first seen and to carefully follow those who present with fewer than four criteria for the development of additional findings over time. (See <a href=\"#H75107910\" class=\"local\">'Classification criteria'</a> below and <a href=\"#H75102600\" class=\"local\">'Hematologic abnormalities'</a> above and <a href=\"#H75107337\" class=\"local\">'Laboratory findings'</a> above.)</p><p>A low index of suspicion for SLE in childhood is the primary impediment to a proper diagnosis. Delayed diagnosis may be due to the frequent absence of the typical findings of SLE at disease onset (eg, malar rash) or may be due to the high frequency of nonspecific complaints, such as weight loss, chronic low-grade fever, or malaise [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/9\" class=\"abstract_t\">9</a>]. There will be many children who do not initially reach sufficient criteria for classification as SLE but who present with two or three manifestations. These children should be monitored over time for the development of additional criteria of SLE. There are examples of children who initially did not meet the definite criteria and were assured that they &quot;did not have SLE.&quot; In these cases, this false assurance led to a marked delay in return to medical care despite worsening symptoms. (See <a href=\"#H75102452\" class=\"local\">'Clinical manifestations'</a> above and <a href=\"#H75107337\" class=\"local\">'Laboratory findings'</a> above.)</p><p>A single manifestation of SLE, such as thrombocytopenia, may predominate early in the course of the disease. Such children should be carefully evaluated for the presence of additional manifestations of SLE, including an elevated antinuclear antibodies (ANAs) titer. Repeated evaluation is necessary as children who initially fulfill less than four of the ACR criteria may progress over time to definitive SLE. Such progression may occur over a period of three to five years or longer and is typically accompanied by the gradual accrual of additional pathologic autoantibodies (eg, anti-Smith [anti-Sm] and anti-Ro) [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/138\" class=\"abstract_t\">138</a>]. (See <a href=\"#H75107337\" class=\"local\">'Laboratory findings'</a> above.)</p><p>Less frequently, some children with SLE present acutely with a fever, rash, leukopenia, and thrombocytopenia; findings that are suggestive of overwhelming infection. The differentiation of SLE from intercurrent sepsis may be difficult and may require simultaneous treatment for both conditions. (See <a href=\"topic.htm?path=systemic-lupus-erythematosus-sle-in-children-treatment-complications-and-prognosis#H75093730\" class=\"medical medical_review\">&quot;Systemic lupus erythematosus (SLE) in children: Treatment, complications, and prognosis&quot;, section on 'Treatment'</a> and <a href=\"topic.htm?path=systemic-inflammatory-response-syndrome-sirs-and-sepsis-in-children-definitions-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Systemic inflammatory response syndrome (SIRS) and sepsis in children: Definitions, epidemiology, clinical manifestations, and diagnosis&quot;</a> and <a href=\"topic.htm?path=septic-shock-in-children-rapid-recognition-and-initial-resuscitation-first-hour\" class=\"medical medical_review\">&quot;Septic shock in children: Rapid recognition and initial resuscitation (first hour)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H75107910\"><span class=\"h1\">CLASSIFICATION CRITERIA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The <a href=\"http://onlinelibrary.wiley.com/doi/10.1002/art.34473/pdf&amp;token=xvm30O72g3bVn6vV/GnkF9JPXsTaNt/t7iU9dZPqFKQqLIJJUw/N+qV8JjdRi2Q7KAIwEoSNjx+FRmvq2cqUwq8AtSQsFLDSFqHlsS1NKKs=&amp;TOPIC_ID=6420\" target=\"_blank\" class=\"external\">Systemic Lupus International Collaborating Clinics (SLICC) group classification criteria</a> for SLE is a revised and validated version of the American College of Rheumatology (ACR) criteria used for adults (<a href=\"image.htm?imageKey=RHEUM%2F86633\" class=\"graphic graphic_table graphicRef86633 \">table 3</a>) [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/23,139\" class=\"abstract_t\">23,139</a>]. These same criteria are also used to classify children [<a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/140,141\" class=\"abstract_t\">140,141</a>]. A patient is classified as having SLE if four or more of the SLICC criteria, including at least one clinical and one immunologic criterion, are present either serially or simultaneously during any interval of observations in the absence of another explanation for the findings. An alternative requirement is positive antinuclear antibodies (ANAs) or anti-double-stranded DNA antibodies (anti-dsDNA) in conjunction with biopsy-proven lupus nephritis. Other factors, such as family history, age, duration of symptoms, and evolution of findings, must be taken into account before classifying a child as having SLE since none of the clinical or immunologic criteria for the classification of SLE are disease specific. Some patients may have severe organ manifestations of lupus without fulfilling classification criteria and must be treated urgently or emergently without waiting for other criteria to develop. (See <a href=\"topic.htm?path=diagnosis-and-differential-diagnosis-of-systemic-lupus-erythematosus-in-adults#H690922880\" class=\"medical medical_review\">&quot;Diagnosis and differential diagnosis of systemic lupus erythematosus in adults&quot;, section on 'Classification criteria'</a> and <a href=\"#H75107738\" class=\"local\">'Diagnosis'</a> above.)</p><p class=\"headingAnchor\" id=\"H75108045\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The major considerations in the differential diagnosis and evaluation of a child with a positive antinuclear antibody (ANA) and multisystem illness are infection and other rheumatic diseases. In addition, children with malignancies such as acute lymphoblastic leukemia may on occasion be ANA positive. (See <a href=\"topic.htm?path=overview-of-the-presentation-and-diagnosis-of-acute-lymphoblastic-leukemia-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Overview of the presentation and diagnosis of acute lymphoblastic leukemia in children and adolescents&quot;</a>.)</p><p>Viral infections in particular may be associated with the transient appearance of ANA. Infection can be differentiated by appropriate cultures and the clinical course, although infection may be present at the time of the initial presentation in children with SLE.</p><p>Mixed connective tissue disease, dermatomyositis, scleroderma, and polyarteritis nodosa all may be associated with a positive ANA and multisystem findings. All but mixed connective tissue disease can be excluded by evaluation of the appropriate tissues (eg, muscle, skin, kidney). Differentiation of mixed connective tissue disease may initially be difficult, but the diagnosis is traditionally made on the basis of hypergammaglobulinemia, relatively normal serum complement levels, and the pattern of ANA subsets. (See <a href=\"topic.htm?path=definition-and-diagnosis-of-mixed-connective-tissue-disease\" class=\"medical medical_review\">&quot;Definition and diagnosis of mixed connective tissue disease&quot;</a> and <a href=\"topic.htm?path=juvenile-dermatomyositis-and-polymyositis-diagnosis\" class=\"medical medical_review\">&quot;Juvenile dermatomyositis and polymyositis: Diagnosis&quot;</a> and <a href=\"topic.htm?path=juvenile-systemic-sclerosis-scleroderma\" class=\"medical medical_review\">&quot;Juvenile systemic sclerosis (scleroderma)&quot;</a> and <a href=\"topic.htm?path=vasculitis-in-children-classification-and-incidence#H8\" class=\"medical medical_review\">&quot;Vasculitis in children: Classification and incidence&quot;, section on 'Polyarteritis nodosa'</a>.)</p><p class=\"headingAnchor\" id=\"H1997915750\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-systemic-lupus-erythematosus\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Systemic lupus erythematosus&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H75108115\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Systemic lupus erythematosus (SLE) is a chronic inflammatory disease of unknown cause that can affect the skin, joints, kidneys, lungs, nervous system, serous membranes, <span class=\"nowrap\">and/or</span> other organs of the body. SLE in children is fundamentally the same disease as in adults, with similar etiology, pathogenesis, clinical manifestations, and laboratory findings. However, the frequency of specific manifestations varies between pediatric- and adult-onset SLE, and the disease may be worse in children if diagnosis is delayed. (See <a href=\"#H75102260\" class=\"local\">'Introduction'</a> above and <a href=\"#H75102434\" class=\"local\">'Pathogenesis'</a> above and <a href=\"#H75102452\" class=\"local\">'Clinical manifestations'</a> above and <a href=\"topic.htm?path=overview-of-the-clinical-manifestations-of-systemic-lupus-erythematosus-in-adults\" class=\"medical medical_review\">&quot;Overview of the clinical manifestations of systemic lupus erythematosus in adults&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The incidence and severity of childhood SLE vary by race. Asians, Africans, and Hispanics are all more frequently affected than Caucasians. (See <a href=\"#H75102290\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The most common initial symptoms are the gradual onset of fever, weight loss, and malaise, with general deterioration over several months. Children also may have small joint arthritis and renal disease, both of which are commonly overlooked before the diagnosis of SLE is established. The classic malar rash is absent in two-thirds of individuals and must not be relied upon to suggest the diagnosis. Hematologic, neuropsychiatric, and pulmonary manifestations are also common. (See <a href=\"#H75102452\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Common laboratory findings in children with SLE, in addition to the hematologic abnormalities, include presence of autoantibodies, such as antinuclear antibodies (ANAs) and antiphospholipid antibodies (aPLs), and vitamin D deficiency. (See <a href=\"#H75107337\" class=\"local\">'Laboratory findings'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The <a href=\"http://onlinelibrary.wiley.com/doi/10.1002/art.34473/pdf&amp;token=xvm30O72g3bVn6vV/GnkF9JPXsTaNt/t7iU9dZPqFKQqLIJJUw/N+qV8JjdRi2Q7KAIwEoSNjx+FRmvq2cqUwq8AtSQsFLDSFqHlsS1NKKs=&amp;TOPIC_ID=6420\" target=\"_blank\" class=\"external\">Systemic Lupus International Collaborating Clinics (SLICC) group classification criteria</a> are used to aid in the diagnosis of SLE in both children and adults. A patient is classified as having SLE if four or more of the SLICC criteria, including at least one clinical and one immunologic criterion, are present either serially or simultaneously during any interval of observations in the absence of another explanation for the findings. An alternative requirement is positive ANAs or anti-double-stranded deoxyribonucleic acid (anti-dsDNA) antibodies in conjunction with biopsy-proven lupus nephritis. (See <a href=\"#H75107738\" class=\"local\">'Diagnosis'</a> above and <a href=\"#H75107910\" class=\"local\">'Classification criteria'</a> above and <a href=\"topic.htm?path=diagnosis-and-differential-diagnosis-of-systemic-lupus-erythematosus-in-adults#H914180\" class=\"medical medical_review\">&quot;Diagnosis and differential diagnosis of systemic lupus erythematosus in adults&quot;, section on 'Our diagnostic criteria'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The differential diagnosis of children with a positive ANA and multisystem disease includes infection, malignancy, and other rheumatic diseases even in the presence of anti-dsDNA antibodies. (See <a href=\"#H75108045\" class=\"local\">'Differential diagnosis'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H3225558204\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate would like to acknowledge Thomas JA Lehman, MD, who contributed to earlier versions of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/1\" class=\"nounderline abstract_t\">Pineles D, Valente A, Warren B, et al. Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus. Lupus 2011; 20:1187.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/2\" class=\"nounderline abstract_t\">Lehman TJ, McCurdy DK, Bernstein BH, et al. Systemic lupus erythematosus in the first decade of life. Pediatrics 1989; 83:235.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/3\" class=\"nounderline abstract_t\">Bader-Meunier B, Armengaud JB, Haddad E, et al. Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr 2005; 146:648.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/4\" class=\"nounderline abstract_t\">Hiraki LT, Benseler SM, Tyrrell PN, et al. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr 2008; 152:550.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/5\" class=\"nounderline abstract_t\">Watson L, Leone V, Pilkington C, et al. Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort. Arthritis Rheum 2012; 64:2356.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/6\" class=\"nounderline abstract_t\">Huang JL, Yeh KW, Yao TC, et al. Pediatric lupus in Asia. Lupus 2010; 19:1414.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/7\" class=\"nounderline abstract_t\">Huang JL, Yao TC, See LC. Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan. Clin Exp Rheumatol 2004; 22:776.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/8\" class=\"nounderline abstract_t\">Al-Arfaj AS, Al-Balla SR, Al-Dalaan AN, et al. Prevalence of systemic lupus erythematosus in central Saudi Arabia. Saudi Med J 2002; 23:87.</a></li><li class=\"breakAll\">Lehman TJ. Systemic lupus erythematosus in children and adolescents. In: Dubois' Systemic Lupus Erythematosus, 5th ed, Wallace DA, Hahn B (Eds), WB Saunders, Philadelphia 1996.</li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/10\" class=\"nounderline abstract_t\">Stichweh D, Arce E, Pascual V. Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol 2004; 16:577.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/11\" class=\"nounderline abstract_t\">Livingston B, Bonner A, Pope J. Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis. Lupus 2011; 20:1345.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/12\" class=\"nounderline abstract_t\">McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49:193.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/13\" class=\"nounderline abstract_t\">Schaller J. Lupus in childhood. Clin Rheum Dis 1982; 8:219.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/14\" class=\"nounderline abstract_t\">JACOBS JC. SYSTEMIC LUPUS ERYTHEMATOSUS IN CHILDHOOD. REPORT OF THIRTY-FIVE CASES, WITH DISCUSSION OF SEVEN APPARENTLY INDUCED BY ANTICONVULSANT MEDICATION, AND OF PROGNOSIS AND TREATMENT. Pediatrics 1963; 32:257.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/15\" class=\"nounderline abstract_t\">Caeiro F, Michielson FM, Bernstein R, et al. Systemic lupus erythematosus in childhood. Ann Rheum Dis 1981; 40:325.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/16\" class=\"nounderline abstract_t\">COOK CD, WEDGWOOD RJ, CRAIG JM, et al. Systemic lupus erythematosus. Description of 37 cases in children and a discussion of endocrine therapy in 32 of the cases. Pediatrics 1960; 26:570.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/17\" class=\"nounderline abstract_t\">Fish AJ, Blau EB, Westberg NG, et al. Systemic lupus erythematosus within the first two decades of life. Am J Med 1977; 62:99.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/18\" class=\"nounderline abstract_t\">King KK, Kornreich HK, Bernstein BH, et al. The clinical spectrum of systemic lupus erythematosus in childhood. Arthritis Rheum 1977; 20:287.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/19\" class=\"nounderline abstract_t\">Schmugge M, Revel-Vilk S, Hiraki L, et al. Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus. J Pediatr 2003; 143:666.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/20\" class=\"nounderline abstract_t\">Seaman DE, Londino AV Jr, Kwoh CK, et al. Antiphospholipid antibodies in pediatric systemic lupus erythematosus. Pediatrics 1995; 96:1040.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/21\" class=\"nounderline abstract_t\">Descloux E, Durieu I, Cochat P, et al. Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies. Rheumatology (Oxford) 2008; 47:183.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/22\" class=\"nounderline abstract_t\">Iqbal S, Sher MR, Good RA, Cawkwell GD. Diversity in presenting manifestations of systemic lupus erythematosus in children. J Pediatr 1999; 135:500.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/23\" class=\"nounderline abstract_t\">Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/24\" class=\"nounderline abstract_t\">Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1725.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/25\" class=\"nounderline abstract_t\">Grigor R, Edmonds J, Lewkonia R, et al. Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis 1978; 37:121.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/26\" class=\"nounderline abstract_t\">Rivero SJ, D&iacute;az-Jouanen E, Alarc&oacute;n-Segovia D. Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. Arthritis Rheum 1978; 21:295.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/27\" class=\"nounderline abstract_t\">HARVEY AM, SHULMAN LE, TUMULTY PA, et al. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954; 33:291.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/28\" class=\"nounderline abstract_t\">Voulgarelis M, Kokori SI, Ioannidis JP, et al. Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin. Ann Rheum Dis 2000; 59:217.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/29\" class=\"nounderline abstract_t\">Wolach B, Choc L, Pomeranz A, et al. Aplastic anemia in neonatal lupus erythematosus. Am J Dis Child 1993; 147:941.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/30\" class=\"nounderline abstract_t\">Alger M, Alarcon-Segovia D, Rivero SJ. Hemolytic anemia and thrombocytopenic purpura: two related subsets of systemic lupus erythematosus. J Rheumatol 1977; 4:351.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/31\" class=\"nounderline abstract_t\">Miescher PA, Tucci A, Beris P, Favre H. Autoimmune hemolytic anemia and/or thrombocytopenia associated with lupus parameters. Semin Hematol 1992; 29:13.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/32\" class=\"nounderline abstract_t\">Karpatkin S, Strick N, Karpatkin MB, Siskind GW. Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders. Am J Med 1972; 52:776.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/33\" class=\"nounderline abstract_t\">Hepburn MJ, English JC 3rd, Keeling JH 3rd. Autoimmune idiopathic thrombocytopenic purpura with the subsequent occurrence of systemic lupus erythematosus. Cutis 1997; 60:185.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/34\" class=\"nounderline abstract_t\">Lepore L, Salvatore CM, Pahor T, et al. Slow evolution to systemic lupus erythematosus of isolated autoimmune thrombocytopenia. Clin Exp Rheumatol 2000; 18:535.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/35\" class=\"nounderline abstract_t\">Mitra S, Marwaha N, Marwaha RK, et al. Immune thrombocytopenic purpura with multiple auto-antibodies: evolution into systemic lupus erythematosus. Indian Pediatr 2000; 37:197.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/36\" class=\"nounderline abstract_t\">Mestanza-Peralta M, Ariza-Ariza R, Cardiel MH, Alcocer-Varela J. Thrombocytopenic purpura as initial manifestation of systemic lupus erythematosus. J Rheumatol 1997; 24:867.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/37\" class=\"nounderline abstract_t\">Karpatkin S. Autoimmune thrombocytopenic purpura. Blood 1980; 56:329.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/38\" class=\"nounderline abstract_t\">Firkin BG, Buchanan RR, Pfueller S, Ryan P. Lupoid thrombocytopenia. Aust N Z J Med 1987; 17:295.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/39\" class=\"nounderline abstract_t\">Bray VJ, West SG, Kristo DA. Simultaneous presentation of thrombotic thrombocytopenic purpura and systemic lupus erythematosus. South Med J 1994; 87:827.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/40\" class=\"nounderline abstract_t\">Brunner HI, Freedman M, Silverman ED. Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. Arthritis Rheum 1999; 42:2346.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/41\" class=\"nounderline abstract_t\">Sakarcan A, Stallworth J. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case and review. Pediatr Nephrol 2001; 16:672.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/42\" class=\"nounderline abstract_t\">Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339:1585.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/43\" class=\"nounderline abstract_t\">Chiewchengchol D, Murphy R, Morgan T, et al. Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients. Rheumatology (Oxford) 2014; 53:1504.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/44\" class=\"nounderline abstract_t\">Compeyrot-Lacassagne S, Tyrrell PN, Atenafu E, et al. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus. Arthritis Rheum 2007; 56:1966.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/45\" class=\"nounderline abstract_t\">Arkachaisri T, Lehman TJ. Systemic lupus erythematosus and related disorders of childhood. Curr Opin Rheumatol 1999; 11:384.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/46\" class=\"nounderline abstract_t\">Yancey CL, Doughty RA, Athreya BH. Central nervous system involvement in childhood systemic lupus erythematosus. Arthritis Rheum 1981; 24:1389.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/47\" class=\"nounderline abstract_t\">Carbotte RM, Denburg SD, Denburg JA. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 1986; 174:357.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/48\" class=\"nounderline abstract_t\">Papero PH, Bluestein HG, White P, Lipnick RN. Neuropsychologic deficits and antineuronal antibodies in pediatric systemic lupus erythematosus. Clin Exp Rheumatol 1990; 8:417.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/49\" class=\"nounderline abstract_t\">Quintero-Del-Rio AI, Van Miller . Neurologic symptoms in children with systemic lupus erythematosus. J Child Neurol 2000; 15:803.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/50\" class=\"nounderline abstract_t\">Benseler SM, Silverman ED. Neuropsychiatric involvement in pediatric systemic lupus erythematosus. Lupus 2007; 16:564.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/51\" class=\"nounderline abstract_t\">Sibbitt WL Jr, Brandt JR, Johnson CR, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002; 29:1536.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/52\" class=\"nounderline abstract_t\">Olfat MO, Al-Mayouf SM, Muzaffer MA. Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus. Clin Rheumatol 2004; 23:395.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/53\" class=\"nounderline abstract_t\">Brunner HI, Ruth NM, German A, et al. Initial validation of the Pediatric Automated Neuropsychological Assessment Metrics for childhood-onset systemic lupus erythematosus. Arthritis Rheum 2007; 57:1174.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/54\" class=\"nounderline abstract_t\">Barsalou J, Levy DM, Silverman ED. An update on childhood-onset systemic lupus erythematosus. Curr Opin Rheumatol 2013; 25:616.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/55\" class=\"nounderline abstract_t\">Amaral B, Murphy G, Ioannou Y, Isenberg DA. A comparison of the outcome of adolescent and adult-onset systemic lupus erythematosus. Rheumatology (Oxford) 2014; 53:1130.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/56\" class=\"nounderline abstract_t\">Hiraki LT, Feldman CH, Liu J, et al. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum 2012; 64:2669.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/57\" class=\"nounderline abstract_t\">Malleson PN. The role of the renal biopsy in childhood onset systemic lupus erythematosus: a viewpoint. Clin Exp Rheumatol 1989; 7:563.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/58\" class=\"nounderline abstract_t\">Delgado EA, Malleson PN, Pirie GE, Petty RE. The pulmonary manifestations of childhood onset systemic lupus erythematosus. Semin Arthritis Rheum 1990; 19:285.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/59\" class=\"nounderline abstract_t\">Glidden RS, Mantzouranis EC, Borel Y. Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in fifty-five patients. Clin Immunol Immunopathol 1983; 29:196.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/60\" class=\"nounderline abstract_t\">Platt JL, Burke BA, Fish AJ, et al. Systemic lupus erythematosus in the first two decades of life. Am J Kidney Dis 1982; 2:212.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/61\" class=\"nounderline abstract_t\">Pohlgeers AP, Eid NS, Schikler KN, Shearer LT. Systemic lupus erythematosus: pulmonary presentation in childhood. South Med J 1990; 83:712.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/62\" class=\"nounderline abstract_t\">de Jongste JC, Neijens HJ, Duiverman EJ, et al. Respiratory tract disease in systemic lupus erythematosus. Arch Dis Child 1986; 61:478.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/63\" class=\"nounderline abstract_t\">Cift&ccedil;i E, Yal&ccedil;inkaya F, Ince E, et al. Pulmonary involvement in childhood-onset systemic lupus erythematosus: a report of five cases. Rheumatology (Oxford) 2004; 43:587.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/64\" class=\"nounderline abstract_t\">Beresford MW, Cleary AG, Sills JA, et al. Cardio-pulmonary involvement in juvenile systemic lupus erythematosus. Lupus 2005; 14:152.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/65\" class=\"nounderline abstract_t\">Al-Abbad AJ, Cabral DA, Sanatani S, et al. Echocardiography and pulmonary function testing in childhood onset systemic lupus erythematosus. Lupus 2001; 10:32.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/66\" class=\"nounderline abstract_t\">Mochizuki T, Aotsuka S, Satoh T. Clinical and laboratory features of lupus patients with complicating pulmonary disease. Respir Med 1999; 93:95.</a></li><li class=\"breakAll\">Moore KL. Clinically oriented anatomy, Williams and Wilkins, Baltimore 1985. p.146.</li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/68\" class=\"nounderline abstract_t\">Quismorio FP Jr. Clinical and pathologic features of lung involvement in systemic lupus erythematosus. Semin Respir Dis 1988; 9:297.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/69\" class=\"nounderline abstract_t\">Trapani S, Camiciottoli G, Ermini M, et al. Pulmonary involvement in juvenile systemic lupus erythematosus: a study on lung function in patients asymptomatic for respiratory disease. Lupus 1998; 7:545.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/70\" class=\"nounderline abstract_t\">Gross M, Esterly JR, Earle RH. Pulmonary alterations in systemic lupus erythematosus. Am Rev Respir Dis 1972; 105:572.</a></li><li class=\"breakAll\">Disorders of the respiratory tract in children, 4th ed, Kendig EL, Chernick V (Eds), WB Saunders, Philadelphia 1983.</li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/72\" class=\"nounderline abstract_t\">Cerveri I, Fanfulla F, Ravelli A, et al. Pulmonary function in children with systemic lupus erythematosus. Thorax 1996; 51:424.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/73\" class=\"nounderline abstract_t\">HOFFBRAND BI, BECK ER. &quot;UNEXPLAINED&quot; DYSPNOEA AND SHRINKING LUNGS IN SYSTEMIC LUPUS ERYTHEMATOSUS. Br Med J 1965; 1:1273.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/74\" class=\"nounderline abstract_t\">Martens J, Demedts M, Vanmeenen MT, Dequeker J. Respiratory muscle dysfunction in systemic lupus erythematosus. Chest 1983; 84:170.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/75\" class=\"nounderline abstract_t\">Gibson CJ, Edmonds JP, Hughes GR. Diaphragm function and lung involvement in systemic lupus erythematosus. Am J Med 1977; 63:926.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/76\" class=\"nounderline abstract_t\">Bernstein RM. Pulmonary function in SLE with a longitudinal study of the shrinking lungs syndrome. Arthritis Rheum 1982; 25 (Suppl):S7.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/77\" class=\"nounderline abstract_t\">Stevens WM, Burdon JG, Clemens LE, Webb J. The 'shrinking lungs syndrome'--an infrequently recognised feature of systemic lupus erythematosus. Aust N Z J Med 1990; 20:67.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/78\" class=\"nounderline abstract_t\">Rubin LA, Urowitz MB. Shrinking lung syndrome in SLE--a clinical pathologic study. J Rheumatol 1983; 10:973.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/79\" class=\"nounderline abstract_t\">Thompson PJ, Dhillon DP, Ledingham J, Turner-Warwick M. Shrinking lungs, diaphragmatic dysfunction, and systemic lupus erythematosus. Am Rev Respir Dis 1985; 132:926.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/80\" class=\"nounderline abstract_t\">Nadorra RL, Landing BH. Pulmonary lesions in childhood onset systemic lupus erythematosus: analysis of 26 cases, and summary of literature. Pediatr Pathol 1987; 7:1.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/81\" class=\"nounderline abstract_t\">Walz-Leblanc BA, Urowitz MB, Gladman DD, Hanly PJ. The &quot;shrinking lungs syndrome&quot; in systemic lupus erythematosus--improvement with corticosteroid therapy. J Rheumatol 1992; 19:1970.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/82\" class=\"nounderline abstract_t\">Eagen JW, Memoli VA, Roberts JL, et al. Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) 1978; 57:545.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/83\" class=\"nounderline abstract_t\">Rajani KB, Ashbacher LV, Kinney TR. Pulmonary hemorrhage and systemic lupus erythematosus. J Pediatr 1978; 93:810.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/84\" class=\"nounderline abstract_t\">Gould DB, Soriano RZ. Acute alveolar hemorrhage in lupus erythematosus. Ann Intern Med 1975; 83:836.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/85\" class=\"nounderline abstract_t\">Ramirez RE, Glasier C, Kirks D, et al. Pulmonary hemorrhage associated with systemic lupus erythematosus in children. Radiology 1984; 152:409.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/86\" class=\"nounderline abstract_t\">Miller RW, Salcedo JR, Fink RJ, et al. Pulmonary hemorrhage in pediatric patients with systemic lupus erythematosus. J Pediatr 1986; 108:576.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/87\" class=\"nounderline abstract_t\">Nair SS, Askari AD, Popelka CG, Kleinerman JF. Pulmonary hypertension and systemic lupus erythematosus. Arch Intern Med 1980; 140:109.</a></li><li class=\"breakAll\">Jacobs JC. Pediatric rheumatology for the practitioner, Springer Verlag, New York 1982.</li><li class=\"breakAll\">Jacobs JC. Pediatric rheumatology for the practitioner, Springer-Verlag, New York 1982.</li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/90\" class=\"nounderline abstract_t\">Buoncompagni A, Barbano GC, Pistoia V, et al. Childhood systemic lupus erythematosus: a review of 30 cases. Clin Exp Rheumatol 1991; 9:425.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/91\" class=\"nounderline abstract_t\">Oshiro AC, Derbes SJ, Stopa AR, Gedalia A. Anti-Ro/SS-A and anti-La/SS-B antibodies associated with cardiac involvement in childhood systemic lupus erythematosus. Ann Rheum Dis 1997; 56:272.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/92\" class=\"nounderline abstract_t\">Gazarian M, Feldman BM, Benson LN, et al. Assessment of myocardial perfusion and function in childhood systemic lupus erythematosus. J Pediatr 1998; 132:109.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/93\" class=\"nounderline abstract_t\">Panchal L, Divate S, Vaideeswar P, Pandit SP. Cardiovascular involvement in systemic lupus erythematosus: an autopsy study of 27 patients in India. J Postgrad Med 2006; 52:5.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/94\" class=\"nounderline abstract_t\">Hunder GG, Mullen BJ, McDuffie FC. Complement in pericardial fluid of lupus erythematosus. Studies in two patients. Ann Intern Med 1974; 80:453.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/95\" class=\"nounderline abstract_t\">Gulati S, Kumar L. Cardiac tamponade as an initial manifestation of systemic lupus erythematosus in early childhood. Ann Rheum Dis 1992; 51:279.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/96\" class=\"nounderline abstract_t\">Lerer RJ. Cardiac tamponade as an initial finding in systemic lupus erythematosus. Am J Dis Child 1972; 124:436.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/97\" class=\"nounderline abstract_t\">Tamura A, Agematsu K, Urasawa R, et al. Cardiac tamponade due to systemic lupus erythematosus in a 7-year-old boy with selective IgG subclass deficiency. Eur J Pediatr 1998; 157:475.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/98\" class=\"nounderline abstract_t\">Malci&#263; I, Seneci&#263; I, Dasovi&#263; A, Radoni&#263; M. [Incipient pericardial tamponade as the first symptom of systemic lupus erythematosus in 2 children]. Reumatizam 1995; 42:19.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/99\" class=\"nounderline abstract_t\">Aiuto LT, Stambouly JJ, Boxer RA. Cardiac tamponade in an adolescent female: an unusual manifestation of systemic lupus erythematosus. Clin Pediatr (Phila) 1993; 32:566.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/100\" class=\"nounderline abstract_t\">Jacobson EJ, Reza MJ. Constrictive pericarditis in systemic lupus erythematosus. Demonstration of immunoglobulins in the pericardium. Arthritis Rheum 1978; 21:972.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/101\" class=\"nounderline abstract_t\">Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1985; 110:1257.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/102\" class=\"nounderline abstract_t\">Strauer BE, Brune I, Schenk H, et al. Lupus cardiomyopathy: cardiac mechanics, hemodynamics, and coronary blood flow in uncomplicated systemic lupus erythematosus. Am Heart J 1976; 92:715.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/103\" class=\"nounderline abstract_t\">Guevara JP, Clark BJ, Athreya BH. Point prevalence of cardiac abnormalities in children with systemic lupus erythematosus. J Rheumatol 2001; 28:854.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/104\" class=\"nounderline abstract_t\">De Inocencio J, Lovell DJ. Cardiac function in systemic lupus erythematosus. J Rheumatol 1994; 21:2147.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/105\" class=\"nounderline abstract_t\">Norris DG, Col&oacute;n AR, Stickler GB. Systemic lupus erythematosus in children: the complex problems of diagnosis and treatment encountered in 101 such patients at the Mayo Clinic. Clin Pediatr (Phila) 1977; 16:774.</a></li><li class=\"breakAll\">Petty RE, Cassidy JT. Systemic lupus erythematosus. In: Textbook of pediatric rheumatology, 4th ed, Cassidy JT, Petty RE (Eds), WB Saunders Company, Philadelphia 2001. p.396.</li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/107\" class=\"nounderline abstract_t\">Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1987; 17:126.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/108\" class=\"nounderline abstract_t\">Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996; 335:1424.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/109\" class=\"nounderline abstract_t\">Roldan CA. Valvular disease associated with systemic illness. Cardiol Clin 1998; 16:531.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/110\" class=\"nounderline abstract_t\">Roldan CA, Shively BK, Lau CC, et al. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 1992; 20:1127.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/111\" class=\"nounderline abstract_t\">Kaplan SD, Chartash EK, Pizzarello RA, Furie RA. Cardiac manifestations of the antiphospholipid syndrome. Am Heart J 1992; 124:1331.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/112\" class=\"nounderline abstract_t\">Farzaneh-Far A, Roman MJ, Lockshin MD, et al. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis Rheum 2006; 54:3918.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/113\" class=\"nounderline abstract_t\">Moyssakis I, Tektonidou MG, Vasilliou VA, et al. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med 2007; 120:636.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/114\" class=\"nounderline abstract_t\">Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42:338.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/115\" class=\"nounderline abstract_t\">Ishikawa S, Segar WE, Gilbert EF, et al. Myocardial infarct in a child with systemic lupus erythematosus. Am J Dis Child 1978; 132:696.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/116\" class=\"nounderline abstract_t\">Friedman DM, Lazarus HM, Fierman AH. Acute myocardial infarction in pediatric systemic lupus erythematosus. J Pediatr 1990; 117:263.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/117\" class=\"nounderline abstract_t\">Englund JA, Lucas RV Jr. Cardiac complications in children with systemic lupus erythematosus. Pediatrics 1983; 72:724.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/118\" class=\"nounderline abstract_t\">Ravenell RL, Kamen DL, Spence JD, et al. Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients. Am J Med Sci 2012; 344:268.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/119\" class=\"nounderline abstract_t\">Sturfelt G, Eskilsson J, Nived O, et al. Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients form a defined population. Medicine (Baltimore) 1992; 71:216.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/120\" class=\"nounderline abstract_t\">Bj&ouml;rn&aring;dal L, Yin L, Granath F, et al. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95. J Rheumatol 2004; 31:713.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/121\" class=\"nounderline abstract_t\">Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349:2399.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/122\" class=\"nounderline abstract_t\">Sarnes E, Crofford L, Watson M, et al. Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review. Clin Ther 2011; 33:1413.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/123\" class=\"nounderline abstract_t\">Spiera H, Rothenberg RR. Myocardial infarction in four young patients with SLE. J Rheumatol 1983; 10:464.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/124\" class=\"nounderline abstract_t\">Tyrrell PN, Beyene J, Benseler SM, et al. Predictors of lipid abnormalities in children with new-onset systemic lupus erythematosus. J Rheumatol 2007; 34:2112.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/125\" class=\"nounderline abstract_t\">Sarkissian T, Beyenne J, Feldman B, et al. The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus. Arthritis Rheum 2006; 54:1283.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/126\" class=\"nounderline abstract_t\">Ilowite NT, Samuel P, Ginzler E, Jacobson MS. Dyslipoproteinemia in pediatric systemic lupus erythematosus. Arthritis Rheum 1988; 31:859.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/127\" class=\"nounderline abstract_t\">Sarkissian T, Beyene J, Feldman B, et al. Longitudinal examination of lipid profiles in pediatric systemic lupus erythematosus. Arthritis Rheum 2007; 56:631.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/128\" class=\"nounderline abstract_t\">Ardoin SP, Sandborg C, Schanberg LE. Management of dyslipidemia in children and adolescents with systemic lupus erythematosus. Lupus 2007; 16:618.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/129\" class=\"nounderline abstract_t\">Huang YL, Chung HT, Chang CJ, et al. Lymphopenia is a risk factor in the progression of carotid intima-media thickness in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 2009; 60:3766.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/130\" class=\"nounderline abstract_t\">Richer O, Ulinski T, Lemelle I, et al. Abdominal manifestations in childhood-onset systemic lupus erythematosus. Ann Rheum Dis 2007; 66:174.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/131\" class=\"nounderline abstract_t\">Berube C, Mitchell L, Silverman E, et al. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study. Pediatr Res 1998; 44:351.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/132\" class=\"nounderline abstract_t\">Reichlin M, Broyles TF, Hubscher O, et al. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease. Arthritis Rheum 1999; 42:69.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/133\" class=\"nounderline abstract_t\">Kiss E, Shoenfeld Y. Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus? Clin Rev Allergy Immunol 2007; 32:37.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/134\" class=\"nounderline abstract_t\">Wright TB, Shults J, Leonard MB, et al. Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr 2009; 155:260.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/135\" class=\"nounderline abstract_t\">Amital H, Szekanecz Z, Sz&uuml;cs G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010; 69:1155.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/136\" class=\"nounderline abstract_t\">Stagi S, Cavalli L, Bertini F, et al. Vitamin D levels in children, adolescents, and young adults with juvenile-onset systemic lupus erythematosus: a cross-sectional study. Lupus 2014; 23:1059.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/137\" class=\"nounderline abstract_t\">Ruiz-Irastorza G, Egurbide MV, Olivares N, et al. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 2008; 47:920.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/138\" class=\"nounderline abstract_t\">Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349:1526.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/139\" class=\"nounderline abstract_t\">Petri M, Orbai AM, Alarc&oacute;n GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64:2677.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/140\" class=\"nounderline abstract_t\">Sag E, Tartaglione A, Batu ED, et al. Performance of the new SLICC classification criteria in childhood systemic lupus erythematosus: a multicentre study. Clin Exp Rheumatol 2014; 32:440.</a></li><li><a href=\"https://www.uptodate.com/contents/systemic-lupus-erythematosus-sle-in-children-clinical-manifestations-and-diagnosis/abstract/141\" class=\"nounderline abstract_t\">Fonseca AR, Gaspar-Elsas MI, Land MG, de Oliveira SK. Comparison between three systems of classification criteria in juvenile systemic lupus erythematous. Rheumatology (Oxford) 2015; 54:241.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 6420 Version 21.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H75108115\"><span>SUMMARY</span></a></li><li><a href=\"#H75102260\" id=\"outline-link-H75102260\">INTRODUCTION</a></li><li><a href=\"#H75102290\" id=\"outline-link-H75102290\">EPIDEMIOLOGY</a></li><li><a href=\"#H75102434\" id=\"outline-link-H75102434\">PATHOGENESIS</a></li><li><a href=\"#H75102452\" id=\"outline-link-H75102452\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H75102600\" id=\"outline-link-H75102600\">Hematologic abnormalities</a><ul><li><a href=\"#H75103037\" id=\"outline-link-H75103037\">- Leukopenia</a></li><li><a href=\"#H75103133\" id=\"outline-link-H75103133\">- Anemia</a></li><li><a href=\"#H75103374\" id=\"outline-link-H75103374\">- Thrombocytopenia</a></li></ul></li><li><a href=\"#H75103685\" id=\"outline-link-H75103685\">Mucocutaneous manifestations</a></li><li><a href=\"#H75103752\" id=\"outline-link-H75103752\">Musculoskeletal involvement</a></li><li><a href=\"#H75103821\" id=\"outline-link-H75103821\">Fever</a></li><li><a href=\"#H75103827\" id=\"outline-link-H75103827\">Neurologic involvement</a></li><li><a href=\"#H75104051\" id=\"outline-link-H75104051\">Renal disease</a></li><li><a href=\"#H75104147\" id=\"outline-link-H75104147\">Pulmonary disease</a><ul><li><a href=\"#H75104535\" id=\"outline-link-H75104535\">- Pleuritis</a></li><li><a href=\"#H75104669\" id=\"outline-link-H75104669\">- Subclinical abnormalities</a></li><li><a href=\"#H75105129\" id=\"outline-link-H75105129\">- Pulmonary hemorrhage</a></li><li><a href=\"#H75105365\" id=\"outline-link-H75105365\">- Pulmonary hypertension</a></li><li><a href=\"#H75105607\" id=\"outline-link-H75105607\">- Pneumonitis</a></li></ul></li><li><a href=\"#H75105701\" id=\"outline-link-H75105701\">Cardiac abnormalities</a><ul><li><a href=\"#H75105945\" id=\"outline-link-H75105945\">- Pericardial disease</a></li><li><a href=\"#H75106209\" id=\"outline-link-H75106209\">- Myocardial disease</a></li><li><a href=\"#H75106332\" id=\"outline-link-H75106332\">- Valvular heart disease</a></li><li><a href=\"#H75106688\" id=\"outline-link-H75106688\">- Coronary artery disease</a></li><li><a href=\"#H75107270\" id=\"outline-link-H75107270\">- Heart failure</a></li></ul></li><li><a href=\"#H75107305\" id=\"outline-link-H75107305\">Gastrointestinal disease</a></li></ul></li><li><a href=\"#H75107337\" id=\"outline-link-H75107337\">LABORATORY FINDINGS</a><ul><li><a href=\"#H75107488\" id=\"outline-link-H75107488\">Autoantibodies</a></li><li><a href=\"#H75107640\" id=\"outline-link-H75107640\">Vitamin D deficiency</a></li></ul></li><li><a href=\"#H75107738\" id=\"outline-link-H75107738\">DIAGNOSIS</a></li><li><a href=\"#H75107910\" id=\"outline-link-H75107910\">CLASSIFICATION CRITERIA</a></li><li><a href=\"#H75108045\" id=\"outline-link-H75108045\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H1997915750\" id=\"outline-link-H1997915750\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H75108115\" id=\"outline-link-H75108115\">SUMMARY</a></li><li><a href=\"#H3225558204\" id=\"outline-link-H3225558204\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ALLRG/6420|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=HEME/64888\" class=\"graphic graphic_figure\">- Immune clearance of red cells</a></li></ul></li><li><div id=\"ALLRG/6420|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/75781\" class=\"graphic graphic_picture\">- Acute cutaneous lupus erythematosus - malar</a></li><li><a href=\"image.htm?imageKey=DERM/55875\" class=\"graphic graphic_picture\">- Acute cutaneous lupus erythematosus - malar eruption</a></li><li><a href=\"image.htm?imageKey=RHEUM/79709\" class=\"graphic graphic_picture\">- Verrucous endocarditis in SLE</a></li></ul></li><li><div id=\"ALLRG/6420|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/64565\" class=\"graphic graphic_table\">- SLE presentation</a></li><li><a href=\"image.htm?imageKey=PEDS/101544\" class=\"graphic graphic_table\">- HGB, HCT, and MCV values in children</a></li><li><a href=\"image.htm?imageKey=RHEUM/86633\" class=\"graphic graphic_table\">- Classification criteria for SLE</a></li><li><a href=\"image.htm?imageKey=CARD/66776\" class=\"graphic graphic_table\">- Clinical features of myocarditis</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-kidney-injury-in-children-clinical-features-etiology-evaluation-and-diagnosis\" class=\"medical medical_review\">Acute kidney injury in children: Clinical features, etiology, evaluation, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=adolescent-eating-habits\" class=\"medical medical_review\">Adolescent eating habits</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anemia-of-chronic-disease-inflammation\" class=\"medical medical_review\">Anemia of chronic disease/inflammation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-child-with-unexplained-thrombocytopenia\" class=\"medical medical_review\">Approach to the child with unexplained thrombocytopenia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=auscultation-of-heart-sounds\" class=\"medical medical_review\">Auscultation of heart sounds</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=autoimmune-hemolytic-anemia-in-children-classification-clinical-features-and-diagnosis\" class=\"medical medical_review\">Autoimmune hemolytic anemia in children: Classification, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-myocarditis-in-children\" class=\"medical medical_review\">Clinical manifestations and diagnosis of myocarditis in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-antiphospholipid-syndrome\" class=\"medical medical_review\">Clinical manifestations of antiphospholipid syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-presentation-evaluation-and-diagnosis-of-the-nonpregnant-adult-with-suspected-acute-pulmonary-embolism\" class=\"medical medical_review\">Clinical presentation, evaluation, and diagnosis of the nonpregnant adult with suspected acute pulmonary embolism</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=constrictive-pericarditis\" class=\"medical medical_review\">Constrictive pericarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=criteria-for-the-diagnosis-of-acute-myocardial-infarction\" class=\"medical medical_review\">Criteria for the diagnosis of acute myocardial infarction</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=definition-and-diagnosis-of-mixed-connective-tissue-disease\" class=\"medical medical_review\">Definition and diagnosis of mixed connective tissue disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-and-classification-of-renal-disease-in-systemic-lupus-erythematosus\" class=\"medical medical_review\">Diagnosis and classification of renal disease in systemic lupus erythematosus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-and-differential-diagnosis-of-systemic-lupus-erythematosus-in-adults\" class=\"medical medical_review\">Diagnosis and differential diagnosis of systemic lupus erythematosus in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diseases-associated-with-atherosclerosis-in-childhood\" class=\"medical medical_review\">Diseases associated with atherosclerosis in childhood</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drug-induced-neutropenia-and-agranulocytosis\" class=\"medical medical_review\">Drug-induced neutropenia and agranulocytosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dyslipidemia-in-children-definition-screening-and-diagnosis\" class=\"medical medical_review\">Dyslipidemia in children: Definition, screening, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-pathogenesis-of-systemic-lupus-erythematosus\" class=\"medical medical_review\">Epidemiology and pathogenesis of systemic lupus erythematosus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gastrointestinal-manifestations-of-systemic-lupus-erythematosus\" class=\"medical medical_review\">Gastrointestinal manifestations of systemic lupus erythematosus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hematologic-manifestations-of-systemic-lupus-erythematosus\" class=\"medical medical_review\">Hematologic manifestations of systemic lupus erythematosus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hemoptysis-in-children\" class=\"medical medical_review\">Hemoptysis in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=immune-thrombocytopenia-itp-in-children-clinical-features-and-diagnosis\" class=\"medical medical_review\">Immune thrombocytopenia (ITP) in children: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=infectious-causes-of-neutropenia\" class=\"medical medical_review\">Infectious causes of neutropenia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=juvenile-dermatomyositis-and-polymyositis-diagnosis\" class=\"medical medical_review\">Juvenile dermatomyositis and polymyositis: Diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=juvenile-systemic-sclerosis-scleroderma\" class=\"medical medical_review\">Juvenile systemic sclerosis (scleroderma)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=musculoskeletal-manifestations-of-systemic-lupus-erythematosus\" class=\"medical medical_review\">Musculoskeletal manifestations of systemic lupus erythematosus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neonatal-lupus-epidemiology-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Neonatal lupus: Epidemiology, pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neurologic-manifestations-of-systemic-lupus-erythematosus\" class=\"medical medical_review\">Neurologic manifestations of systemic lupus erythematosus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neuropsychiatric-manifestations-of-systemic-lupus-erythematosus\" class=\"medical medical_review\">Neuropsychiatric manifestations of systemic lupus erythematosus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-acute-pulmonary-embolism-in-adults\" class=\"medical medical_review\">Overview of acute pulmonary embolism in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-cutaneous-lupus-erythematosus\" class=\"medical medical_review\">Overview of cutaneous lupus erythematosus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-pulmonary-function-testing-in-children\" class=\"medical medical_review\">Overview of pulmonary function testing in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-clinical-manifestations-of-systemic-lupus-erythematosus-in-adults\" class=\"medical medical_review\">Overview of the clinical manifestations of systemic lupus erythematosus in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-presentation-and-diagnosis-of-acute-lymphoblastic-leukemia-in-children-and-adolescents\" class=\"medical medical_review\">Overview of the presentation and diagnosis of acute lymphoblastic leukemia in children and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathophysiology-of-acquired-ttp-and-other-primary-thrombotic-microangiopathies-tmas\" class=\"medical medical_review\">Pathophysiology of acquired TTP and other primary thrombotic microangiopathies (TMAs)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pulmonary-manifestations-of-systemic-lupus-erythematosus-in-adults\" class=\"medical medical_review\">Pulmonary manifestations of systemic lupus erythematosus in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=recurrent-pericarditis\" class=\"medical medical_review\">Recurrent pericarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=risk-factors-and-development-of-atherosclerosis-in-childhood\" class=\"medical medical_review\">Risk factors and development of atherosclerosis in childhood</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=septic-shock-in-children-rapid-recognition-and-initial-resuscitation-first-hour\" class=\"medical medical_review\">Septic shock in children: Rapid recognition and initial resuscitation (first hour)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-systemic-lupus-erythematosus\" class=\"medical medical_society_guidelines\">Society guideline links: Systemic lupus erythematosus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=systemic-inflammatory-response-syndrome-sirs-and-sepsis-in-children-definitions-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Systemic inflammatory response syndrome (SIRS) and sepsis in children: Definitions, epidemiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=systemic-lupus-erythematosus-sle-in-children-treatment-complications-and-prognosis\" class=\"medical medical_review\">Systemic lupus erythematosus (SLE) in children: Treatment, complications, and prognosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vasculitis-in-children-classification-and-incidence\" class=\"medical medical_review\">Vasculitis in children: Classification and incidence</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vitamin-d-insufficiency-and-deficiency-in-children-and-adolescents\" class=\"medical medical_review\">Vitamin D insufficiency and deficiency in children and adolescents</a></li></ul></div></div>","javascript":null}